or Try an Advanced Search...

    Non Small Cell Lung Cancer Stocks List

    Symbol Grade Name % Change
    OPK B OPKO Health Inc. -0.32
    CNTA B Centessa Pharmaceuticals plc 0.51
    XOMA B XOMA Corporation -0.10
    AVBP C ArriVent BioPharma, Inc. 0.18
    NVCR C NovoCure Limited -1.42
    PYXS C Pyxis Oncology, Inc. -45.94
    HCM C Hutchison China MediTech Limited -0.78
    PBYI C Puma Biotechnology Inc 1.41
    VCNX D Vaccinex, Inc. 1.62
    APLM D Apollomics Inc. -24.30
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Cancer Small Cell Lung Cancer Medicine Solid Tumors Antineoplastic Drugs Biotechnology Clinical Medicine Immunology Treatment Of Non Small Cell Lung Cancer Acute Myeloid Leukemia Antibodies Antibody Biopharmaceutical Cancer Treatment Chemotherapy Clinical Trial Epidermal Growth Factor Receptor Human Monoclonal Antibodies Immune System Immunotherapy

    Related ETFs - A few ETFs which own one or more of the above listed Non Small Cell Lung Cancer stocks.

    Symbol Grade Name Weight
    PBE D PowerShares Dynamic Biotech & Genome 2.78
    OZEM F Roundhill GLP-1 & Weight Loss ETF 1.72
    XHE B SPDR S&P Health Care Equipment 1.65
    CNCR F Loncar Cancer Immunotherapy ETF 1.54
    HTEC C Robo Global Healthcare Technology and Innovation ETF 1.5
    View all Non Small Cell Lung Cancer ETFs...
    Compare ETFs
    Compare OZEM to HTEC Compare PBE to CNCR Compare PBE to XHE

        Non Small Cell Lung Cancer Stocks Recent News

        Date Stock Title
        Nov 21 NVCR Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma
        Nov 21 NVCR FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
        Nov 20 PYXS Pyxis Oncology plummets 38% on preliminary phase 1 data for cancer asset
        Nov 20 PYXS Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data
        Nov 20 PBYI Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
        Nov 20 OPK OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference
        Nov 18 OPK NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo
        Nov 16 OPK Bitdeer Technologies, PBF Energy, and More Stocks See Action From Activist Investors
        Nov 15 AVBP ArriVent BioPharma GAAP EPS of -$0.61 beats by $0.11
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Cancer Small Cell Lung Cancer Medicine Solid Tumors Antineoplastic Drugs Biotechnology Clinical Medicine Immunology Treatment Of Non Small Cell Lung Cancer Acute Myeloid Leukemia Antibodies Antibody Biopharmaceutical Cancer Treatment Chemotherapy Clinical Trial Epidermal Growth Factor Receptor Human Monoclonal Antibodies Immune System Immunotherapy
        Non Small Cell Lung Cancer

        Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of all cases. It is a type of cancer that begins in the cells that line the airways of the lungs. NSCLC is divided into three main subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Symptoms of NSCLC include a persistent cough, chest pain, shortness of breath, and coughing up blood. Treatment options for NSCLC include surgery, chemotherapy, radiation therapy, and targeted therapy.

        Browse All Tags